Search Results - Ryan McIntire
- Showing 1 - 5 results of 5
-
1
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials by Matthew Rashid, Eli Oldham, Griffin K. Hughes, Andriana M. Peña, Chase Ladd, Brooke Gardner, Ryan McIntire, Bradley Johnson, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar
Published in Journal of Urologic Oncology (2024-11-01)Get full text
Article -
2
Assessing patient risk, benefit, and outcomes in drug development: a decade of vemurafenib clinical trials by Taylor Gardner, Jacob Duncan, Griffin K. Hughes, Ryan McIntire, Brooke Gardner, Andriana Peña, Chase Ladd, Kelsey Snider, Ryan Ottwell, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar
Published in Melanoma Management (2025-05-01)Get full text
Article -
3
Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials by Matt Vassar, Vinay Prasad, Ryan McIntire, Alyson Haslam, Brody Dennis, Chance Bratten, Griffin K Hughes, Andriana M Peña, Chase Ladd, Brooke Gardner, William Nowlin, Reagan Livingston, Jordan Tuia
Published in BMJ Oncology (2024-07-01)Get full text
Article -
4
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials by Adam Khan, Hassan Khan, Griffin K. Hughes, Chase Ladd, Ryan McIntire, Brooke Gardner, Andriana M. Peña, Abigail Schoutko, Jordan Tuia, Kirstien Minley, Alyson Haslam, Vinay Prasad, Matt Vassar
Published in Cancer Medicine (2024-05-01)Get full text
Article -
5
An evaluation of selinexor’s clinical trial portfolio: a cross-sectional study by Annes Elfar, Andrew V. Tran, Joseph Case, Cole Wayant, Griffin K. Hughes, Ryan McIntire, Brooke Gardner, Chase Ladd, Andriana M. Peña, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar
Published in Therapeutic Advances in Hematology (2025-05-01)Get full text
Article